ARTICLE | Clinical News
I-vation Implant: Suspended Phase IIb enrollment
August 18, 2008 7:00 AM UTC
SurModics said partner Merck suspended enrollment of a Phase IIb trial of I-vation triamcinolone acetonide (TA) in patients with diabetic macular edema (DME). SurModics said Merck is reevaluating the ...